US FDA Exploring Consortium To Develop Treatments For ‘Economically Infeasible’ Cancer Indications

 
• By Derrick Gingery
  
drug development
The public-private consortium could represent a substantial expansion of the FDA's Project Catalyst. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from R&D

More from Pink Sheet